Ratings by Citi (Brendan Digan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/30/2026 | Stevanato Group S.p.A. | STVN | New Coverage | Buy (N/A) |
20.41 (21.06) |
3.18% | Details | |
| 7/30/2026 | Sotera Health | SHC | New Coverage | Buy (N/A) |
17.53 (18.89) |
7.76% | Details | |
| 7/30/2026 | Qiagen NV | QGEN | New Coverage | Neutral (N/A) |
41.81 (42.95) |
2.73% | Details | |
| 7/30/2026 | Natera | NTRA | New Coverage | Buy (N/A) |
253.82 (309.93) |
22.11% | Details | |
| 7/30/2026 | ICON plc | ICLR | New Coverage | Neutral (N/A) |
178.18 (163.15) |
-8.44% | Details | |
| 7/30/2026 | Guardant Health | GH | New Coverage | Buy (N/A) |
144.07 (157.21) |
9.12% | Details | |
| 7/30/2026 | Fortrea | FTRE | New Coverage | Buy (N/A) |
20.40 (17.41) |
-14.66% | Details | |
| 7/30/2026 | Caris Life Sciences Inc | CAI | New Coverage | Buy (N/A) |
15.59 (21.80) |
39.83% | Details | |
| 7/30/2026 | Bruker | BRKR | New Coverage | Neutral (N/A) |
61.74 (57.70) |
-6.54% | Details | |
| 7/30/2026 | 10X Genomics | TXG | New Coverage | Neutral (N/A) |
46.32 (56.09) |
21.09% | Details |
